1,349 reports of this reaction
3.7% of all ZIPRASIDONE reports
#1 most reported adverse reaction
DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for ZIPRASIDONE, manufactured by ROERIG. There are 1,349 FDA adverse event reports linking ZIPRASIDONE to DRUG INEFFECTIVE. This represents approximately 3.7% of all 36,171 adverse event reports for this drug.
Patients taking ZIPRASIDONE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among ZIPRASIDONE users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for ZIPRASIDONE:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 1,349 FDA reports for ZIPRASIDONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 3.7% of all adverse event reports for ZIPRASIDONE, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking ZIPRASIDONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.